Raymond Bain, Ph.D.
Vice President, Biostatistics & Research Decision Sciences
MERCK & CO.
Menghis Bairus, M.D.
EVP, Chief Medical Officer & Head of Global Drug Development
ELAN PHARMACEUTICALS
Janet Brennan
Executive Vice President & Chief International Affairs Officer
RPS
Christine Burns, Ph.D.
Vice President, Research & Development
AUSHON BIOSYSTEMS
James Cai, Ph.D.
Vice President, Clinical Development
ATYR PHARMA
Helen Chen, Ph.D.
Associate Chief & Senior Investigator
NATIONAL CANCER INSTITUTE
Kexin Chen, M.D., Ph.D.
Director & Professor
TIANJIN MEDICAL UNIVERSITY CANCER INSTITUTE
Xiaoxiang Chen, M.D.
Vice President
BOEHRINGER-INGELHEIM CHINA
Xun Chen
Head of Clinical Sciences & Operations
SANOFI-AVENTIS CHINA
Esther Chu
Director, Global Clinical Operations – Asia-Pacific
BAUSCH & LOMB
Irene Deng
Head of DRA, Oncology Business Unit
BEIJING NOVARTIS PHARMA
Ruiping Dong, M.D., Ph.D.
Vice President, Head of R&D, China & Japan
BRISTOL-MYERS SQUIBB
Kon K. Fung, Ph.D.
Senior Director, Biometrics & Clinical Data Systems
JOHNSON & JOHNSON
Sandy Furey, M.D., Ph.D.
Vice President
PFIZER CONSUMER HEALTHCARE
James Garner, M.D.
Vice President & General Manager
TAKEDA CLINICAL RESEARCH SINGAPORE
Lihong Gu
Executive Vice President
CHINA NON-PRESCRIPTIONS MEDICINES ASSOCIATION
Peter T.C. Ho, M.D., Ph.D.
President
BEIGENE
Jie Hou
Director, Phase I Center
FOUNTAIN MEDICAL DEVELOPMENT
Laurence Huang
Regulatory Affairs Director
ASTRAZENECA
Pearl Huang, Ph.D.
Vice President, Oncology Franchise Integrator
MERCK & CO.
Lih-Jiuan Hsu, M.D.
Division Director, Clinical Medicine
CENTER FOR DRUG EVALUATION-TAIWAN
Min Irwin, M.D., Ph.D.
Medical Director of BSP
BAYER HEALTHCARE
Ming Ji, M.D.
Sr. Medical Director, Clinical Safety Evaluation/Global PV
ABBOTT LABORATORIES
Frank JianG, M.D., Ph.D.
Vice President, Global R&D, Head, China R&D
SANOFI-AVENTIS
Joanne Jiang
Vice President
FOUNTAIN MEDICAL DEVELOPMENT
Jason Jin, M.D., Ph.D.
Chief Executive Officer
SHANGHAI BIOCHIP CORPORATION
Jennifer Jin
Executive Director, Human Resources
BEIJING NOVARTIS PHARMA
Nadina Jose, M.D.
Director, Clinical Site Monitoring & Project Management
ALLERGAN
Chris Kao
Associate Principal, Global Life Sciences Practice
HEIDRICK & STRUGGLES
Derick Lau, M.D., Ph.D.
Professor, Division of Hematology/Oncology
UNIVERSITY OF CALIFORNIA AT DAVIS
Jeff Lee
Director, Northern China
MERCER
Stanley Lech, B.S., Chem, MBA
Vice President of Venture Group & Strategic Relationships
GLAXOSMITHKLINE CONSUMER HEALTHCARE
Ning Li, M.D., Ph.D.
Senior Group Regulatory & Medical Policy Director
SANOFI-AVENTIS CHINA
Qing Li, M.D., Ph.D.
Director, Global Medical Affairs & Clinical Research
JOHNSON & JOHNSON CONSUMER & PERSONAL PRODUCTS
Simon Li, M.D., Ph.D.
Global Clinical Leader, PC
BAYER HEALTHCARE
Tong Li, M.D., Ph.D.
Dir. of CV & Metabolic Disease, Discovery Medicine & Clinical Pharmaocol.
BRISTOL-MYERS SQUIBB
Albert Liou, Ph.D.
Corporate Vice President & General Manager
PAREXEL
Chloe Liu, Ph.D.
Managing Partner
MODULAR R&D
Daniel Liu
Director, China Development
MEDIDATA SOLUTIONS
Feng (Roger) Luo, Ph.D.
Director, Translational Medicine & Early Development
ORTHO BIOTECH ONCOLOGY R&D/CENTOCOR R&D
Richard Lush, M.D.
Executive Director, Clinical Research Operations
MOFFITT CANCER CENTER
Janice Ma
Managing Director
CHINAGATE |
Bradley Marchant, M.D.
Head of Clinical Medicine, Asia
PFIZER CHINA R&D CENTER
David K. Marks
Senior Director & Global Head, Quality Management
RPS
Yuan Meng
Head of Country Pharmacovigilance (Greater China)
BRISTOL-MYERS SQUIBB
Ding Ming, M.D., Ph.D.
Senior Director, CHC Medicine
BOEHRINGER-INGELHEIM
Ole Molskov Bech, M.D., Ph.D.
Vice President, Clinical & Medical Director
NOVO NORDISK CHINA
Fidela Moreno, M.D., Ph.D.
Vice President, Global Development Operations
ALLERGAN
Michael O'Neal, M.D.
Chief Medical Officer
RADPHARM
Lynn Pawelski
Vice President, Regulatory Affairs
JOHNSON & JOHNSON
Bin Peng, M.D., Ph.D.
Senior Director, Head of Oncology Translational Medicine China
NOVARTIS
Catherine Qin
Consultant-Pharmaceutical Division
THE MRI CHINA GROUP
Prof. ShuKui Qin
President
CHINESE SOCIETY FOR CLINICAL ONCOLOGISTS (CSCO)
Kenneth J. Pienta, M.D.
Director, Michigan Institute for Clinical and Health Research
UNIVERSITY OF MICHIGAN SCHOOL OF MEDICINE
Mace Rothenberg, M.D.
Senior Vice President, Clinical Development & Medical Affairs
PFIZER ONCOLOGY
Eric Rubin, Ph.D.
Vice President, Oncology Clinical Research
MERCK & CO.
Samir Shah
Vice President, Global Strategic Development
RPS
Michael Song, M.D.
Medical Director, Immunology
CENTOCOR R&D
Frank Shen, Ph.D.
Head of Biometrics & Clinical Management
ROCHE PHARMA DEVELOPMENT CENTER
Yan Yan Starkey, M.D., MBA
Medical Director-Global Medical Affairs
GLAXOSMITHKLINE CONSUMER HEALTHCARE
Ling Su, Ph.D.
Senior Vice President, Head of Development China
NOVARTIS
Hiroshi Sugii
Vice President, Development Division/Dir., Clinical Development Dept.
NOVO NORDISK JAPAN
He Sun, Ph.D.
Vice President, International Operation
TIAN-SHI-LI PHARMACEUTICALS
Claire Tan
Senior Director, Biostatistics
QUINTILES
Fenlai Tan, M.D., Ph.D.
Beijing R&D Center
ZHEJIANG BETA PHARMA
Tom Tang, M.D., MBA
Vice President, Clinical & Regulatory Affairs
HUTCHISON MEDIPHARMA
Vicky Tao
Director, Medical Regulatory Affairs
ROCHE DIAGNOSTICS SHANGHAI
Anthony Tolcher, M.D.
Director of Clinical Research
SOUTH TEXAS ACCELERATED RESEARCH THERAPEUTICS
Christopher Ung
Vice President, Strategic Business & Operations, Oncology
QUINTILES
Peng Wang, Ph.D.
Chief Scientific Officer
SIMCERE PHARMACEUTICAL GROUP
Simon Wang
Manager
PAREXEL
William Wang, Ph.D.
Head, Asia Pacific Op., Biostats & Research Decision Sciences
MERCK & CO
Zaiqi Wang, M.D., Ph.D.
Director of Clinical Research
MSD TRANSLATIONAL MEDICINE RESEARCH CENTER SINGAPORE
George Wilding, M.D.
Director, Assistant Dean for Oncology
UNIVERSITY OF WISCONSIN
Yan Wu, Ph.D.
Medical & Clinical Development Director
BIOGEN IDEC CHINA
Crystal Xu, M.D.
Director of Medical & Regulatory Affairs
GENZYME
Songlin Xue, M.D., Ph.D.
Senior Vice President and Global Head of Pharmacovigilance
TAKEDA PHARMACEUTICALS
Li Yan, M.D., Ph.D.
Director, Clinical Oncology
MERCK & CO.
Peter Yan
Technical Manager, caBIG Program/CBIIT
NATIONAL CANCER INSTITUTE/SAIC-FREDERICK
Dajun Yang, Ph.D.
Chief Executive Officer
ASCENTAGE PHARMA GROUP
Hyunju Yang
Director of Medical Division
DAIICHI SANKYO KOREA
Dan Zhang, M.D.
Chief Executive Officer
FOUNTAIN MEDICAL DEVELOPMENT
Wei Zhou, Ph.D.
Director, Molecular Epidemiology
PFIZER ONCOLOGY
Zhenping Zhu, Ph.D.
President & Chief Executive Officer
KADMON CHINA |
